Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Non-cash Items (2016 - 2017)

Ultragenyx Pharmaceutical (RARE) has disclosed Non-cash Items for 2 consecutive years, with $37.7 million as the latest value for Q4 2017.

  • On a quarterly basis, Non-cash Items fell 52.38% to $37.7 million in Q4 2017 year-over-year; TTM through Dec 2017 was $37.7 million, a 52.38% decrease, with the full-year FY2017 number at $37.7 million, down 52.38% from a year prior.
  • Non-cash Items was $37.7 million for Q4 2017 at Ultragenyx Pharmaceutical, down from $79.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $79.1 million in Q4 2016 to a low of $37.7 million in Q4 2017.